New Paradigm for Translational Modeling to Predict Long-term Tuberculosis Treatment Response-Reference-Cited by-同舟云学术

New Paradigm for Translational Modeling to Predict Long-term Tuberculosis Treatment Response

Author:

Bartelink IH¹²,Zhang N¹³,Keizer RJ¹⁴,Strydom N¹,Converse PJ³,Dooley KE³,Nuermberger EL³,Savic RM¹

Affiliation:

1. Department of Bioengineering and Therapeutic Sciences; University of California San Francisco; California USA

2. Department of Medicine; University of California; San Francisco California USA

3. Center for Tuberculosis Research; Department of Medicine; Johns Hopkins University School of Medicine; Baltimore Maryland USA

4. InsightRX, a company developing dose optimization software for hospitals

Funder

Bill and Melinda Gates Foundation

U.S. Food and Drug Administration

Global Alliance for TB Drug Development

Clinical Pharmacology

National Institutes of Health

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

Reference47 articles.

1. World Health Organization http://www.who.int/tb/publications/global_report/en/ 2016

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

5. Multiomics technologies applied to tuberculosis drug discovery;Biological Insights of Multi-Omics Technologies in Human Diseases;2024